VIROPHARMA INC
CIK 0000946840
Revenue (TTM)
—
Q3 Oct 2013
Net Income (TTM)
$39.46M
+88.3% YoY
Q3 Oct 2013
EPS Diluted (TTM)
−$0.98
+14.3% YoY
Q3 Oct 2013
Gross Margin
—
Q3 Oct 2013
Operating Margin
—
Q3 Oct 2013
Net Margin
—
Q3 Oct 2013
Free Cash Flow (TTM)
$167.66M
Q3 Oct 2013
Cash
$205.59M
Q3 Oct 2013
Total Debt
$159.63M
Q3 Oct 2013
Shares Outstanding
65.91M sh
Q3 Oct 2013
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.